Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $51.6 million.

  • National Healthcare's Other Accumulated Expenses rose 3845.1% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year increase of 3845.1%. This contributed to the annual value of $21.4 million for FY2024, which is 702.01% down from last year.
  • As of Q3 2025, National Healthcare's Other Accumulated Expenses stood at $51.6 million, which was up 3845.1% from $38.5 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Other Accumulated Expenses ranged from a high of $51.6 million in Q3 2025 and a low of $17.6 million during Q4 2022
  • Its 5-year average for Other Accumulated Expenses is $26.4 million, with a median of $24.1 million in 2022.
  • In the last 5 years, National Healthcare's Other Accumulated Expenses crashed by 2839.02% in 2021 and then surged by 5851.96% in 2025.
  • Quarter analysis of 5 years shows National Healthcare's Other Accumulated Expenses stood at $20.1 million in 2021, then dropped by 12.18% to $17.6 million in 2022, then soared by 30.52% to $23.0 million in 2023, then dropped by 7.02% to $21.4 million in 2024, then skyrocketed by 141.51% to $51.6 million in 2025.
  • Its last three reported values are $51.6 million in Q3 2025, $38.5 million for Q2 2025, and $27.3 million during Q1 2025.